BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $605,000 | +3.8% | 4,000 | 0.0% | 0.26% | +13.3% |
| Q2 2022 | $583,000 | +23.0% | 4,000 | 0.0% | 0.23% | +49.4% |
| Q1 2022 | $474,000 | -14.0% | 4,000 | 0.0% | 0.16% | -7.1% |
| Q4 2021 | $551,000 | -0.9% | 4,000 | 0.0% | 0.17% | -8.2% |
| Q3 2021 | $556,000 | +43.3% | 4,000 | 0.0% | 0.18% | +45.2% |
| Q2 2021 | $388,000 | +42.1% | 4,000 | 0.0% | 0.13% | +32.6% |
| Q1 2021 | $273,000 | -20.4% | 4,000 | 0.0% | 0.10% | -25.2% |
| Q4 2020 | $343,000 | +31.9% | 4,000 | 0.0% | 0.13% | +16.5% |
| Q3 2020 | $260,000 | -11.0% | 4,000 | 0.0% | 0.11% | -18.0% |
| Q2 2020 | $292,000 | +33.9% | 4,000 | 0.0% | 0.13% | +47.8% |
| Q4 2019 | $218,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |